Abstract:Arabidopsis thaliana cryptochrome 2 (AtCRY2), a light-sensitive photosensory protein, was previously adapted for use controling protein-protein interactions through light-dependent binding to a partner protein, CIB1. While the existing CRY2/CIB dimerization system has been used extensively for optogenetic applications, some limitations exist. Here, we set out to optimize function of the CRY2/CIB system, to identify versions of CRY2/CIB that are smaller, show reduced dark interaction, and maintain longer or sho… Show more
“…Later, its natural
oligomerization ability was used in optogenetic clustering approaches 9 . Further tuning of the engineered
light-activatable systems led to a design of the new generation of dimerizers for
advanced control of the protein localization 10 , cell signaling 11 and recombinase activity 12 . All these optogenetic systems sense 440–480 nm light.…”
Multifunctional optogenetic systems are in high demand for use in basic
and biomedical research. Near-infrared-light-inducible binding of bacterial
phytochrome BphP1 to its natural PpsR2 partner is beneficial for simultaneous
use with blue-light-activatable tools. However, applications of the
BphP1–PpsR2 pair are limited by the large size, multidomain structure and
oligomeric behavior of PpsR2. Here, we engineered a single-domain BphP1 binding
partner, Q-PAS1, which is three-fold smaller and lacks oligomerization. We
exploited a helix–PAS fold of Q-PAS1 to develop several
near-infrared-light-controllable transcription regulation systems, enabling
either 40-fold activation or inhibition. The light-induced BphP1–Q-PAS1
interaction allowed modification of the chromatin epigenetic state. Multiplexing
the BphP1–Q-PAS1 pair with a blue-light-activatable LOV-domain-based
system demonstrated their negligible spectral crosstalk. By integrating the
Q-PAS1 and LOV domains in a single optogenetic tool, we achieved tridirectional
protein targeting, independently controlled by near-infrared and blue light,
thus demonstrating the superiority of Q-PAS1 for spectral multiplexing and
engineering of multicomponent systems.
“…Later, its natural
oligomerization ability was used in optogenetic clustering approaches 9 . Further tuning of the engineered
light-activatable systems led to a design of the new generation of dimerizers for
advanced control of the protein localization 10 , cell signaling 11 and recombinase activity 12 . All these optogenetic systems sense 440–480 nm light.…”
Multifunctional optogenetic systems are in high demand for use in basic
and biomedical research. Near-infrared-light-inducible binding of bacterial
phytochrome BphP1 to its natural PpsR2 partner is beneficial for simultaneous
use with blue-light-activatable tools. However, applications of the
BphP1–PpsR2 pair are limited by the large size, multidomain structure and
oligomeric behavior of PpsR2. Here, we engineered a single-domain BphP1 binding
partner, Q-PAS1, which is three-fold smaller and lacks oligomerization. We
exploited a helix–PAS fold of Q-PAS1 to develop several
near-infrared-light-controllable transcription regulation systems, enabling
either 40-fold activation or inhibition. The light-induced BphP1–Q-PAS1
interaction allowed modification of the chromatin epigenetic state. Multiplexing
the BphP1–Q-PAS1 pair with a blue-light-activatable LOV-domain-based
system demonstrated their negligible spectral crosstalk. By integrating the
Q-PAS1 and LOV domains in a single optogenetic tool, we achieved tridirectional
protein targeting, independently controlled by near-infrared and blue light,
thus demonstrating the superiority of Q-PAS1 for spectral multiplexing and
engineering of multicomponent systems.
“…However, this system has potential drawbacks. First, the dissociation reaction has slow kinetics and is uncontrollable, though faster dissociation mutants of the CRY2-CIB1 pair have been reported recently (15). Second, the use of blue light for photoactivation of the CRY2-CIB1 is not compatible with fluorescence imaging with GFP-based biosensors such as FRET biosensors (16,17).…”
Optogenetics is a powerful tool to precisely manipulate cell signaling in space and time. For example, protein activity can be regulated by several light-induced dimerization (LID) systems. Among them, the phytochrome B (PhyB)–phytochrome-interacting factor (PIF) system is the only available LID system controlled by red and far-red lights. However, the PhyB–PIF system requires phycocyanobilin (PCB) or phytochromobilin as a chromophore, which must be artificially added to mammalian cells. Here, we report an expression vector that coexpresses HO1 and PcyA with Ferredoxin and Ferredoxin-NADP+ reductase for the efficient synthesis of PCB in the mitochondria of mammalian cells. An even higher intracellular PCB concentration was achieved by the depletion of biliverdin reductase A, which degrades PCB. The PCB synthesis and PhyB–PIF systems allowed us to optogenetically regulate intracellular signaling without any external supply of chromophores. Thus, we have provided a practical method for developing a fully genetically encoded PhyB–PIF system, which paves the way for its application to a living animal.
“…However, systems that might be sensitive to low transgene expression levels in the “off” state, such as angiogenic sprouting, should use CIB1 N -Cre C . Moreover, next-generation versions of the light-inducible Cre recombinase may facilitate even greater control over levels of induced recombination and downstream effects 58 . Therefore the options for tight control and flexible dynamic range of the system, coupled with the ability to induce sustained effects with transient stimuli in a spatiotemporally controlled fashion, will enable many applications in tissue engineering, synthetic biology, gene therapy, and basic science.…”
The precise spatial and temporal control of gene expression, cell differentiation, and tissue morphogenesis has widespread application in regenerative medicine and the study of tissue development. In this work, we applied optogenetics to control cell differentiation and new tissue formation. Specifically, we engineered an optogenetic “on” switch that provides permanent transgene expression following a transient dose of blue light illumination. To demonstrate its utility in controlling cell differentiation and reprogramming, we incorporated an engineered form of the master myogenic factor MyoD into this system in multipotent cells. Illumination of cells with blue light activated myogenic differentiation, including upregulation of myogenic markers and fusion into multinucleated myotubes. Cell differentiation was spatially patterned by illumination of cell cultures through a photomask. To demonstrate the application of the system to controlling in vivo tissue development, the light inducible switch was used to control the expression of VEGF and angiopoietin-1, which induced angiogenic sprouting in a mouse dorsal window chamber model. Live intravital microscopy showed illumination-dependent increases in blood-perfused microvasculature. This optogenetic switch is broadly useful for applications in which sustained and patterned gene expression is desired following transient induction, including tissue engineering, gene therapy, synthetic biology, and fundamental studies of morphogenesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.